| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.28B | 32.10B | 29.45B | 23.07B | 8.46B | 7.81B |
| Gross Profit | 8.13B | 7.58B | 7.91B | 5.36B | 164.00M | -1.10B |
| EBITDA | 6.05B | 6.83B | 4.43B | 2.20B | -2.25B | -3.56B |
| Net Income | 3.13B | 2.73B | 2.65B | 431.00M | -2.93B | -6.93B |
Balance Sheet | ||||||
| Total Assets | 43.99B | 43.80B | 37.68B | 39.30B | 34.41B | 30.26B |
| Cash, Cash Equivalents and Short-Term Investments | 9.35B | 9.80B | 6.81B | 9.57B | 7.91B | 5.88B |
| Total Debt | 14.81B | 17.34B | 16.08B | 19.98B | 19.61B | 15.68B |
| Total Liabilities | 38.03B | 37.63B | 34.40B | 37.28B | 33.56B | 28.95B |
| Stockholders Equity | 5.95B | 6.17B | 3.27B | 2.02B | 840.00M | 1.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.56B | 1.32B | 960.00M | -885.00M | -5.24B |
| Operating Cash Flow | 0.00 | 6.37B | 4.86B | 4.83B | -141.00M | -3.30B |
| Investing Cash Flow | 0.00 | -2.50B | -3.42B | -3.46B | -181.00M | 1.56B |
| Financing Cash Flow | 0.00 | -1.18B | -5.19B | -56.00M | 2.23B | 3.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $32.58B | 12.18 | 28.67% | 1.56% | 14.75% | 71.73% | |
78 Outperform | $24.99B | 7.73 | 56.20% | 2.15% | 9.38% | 21.02% | |
78 Outperform | $38.22B | 8.25 | 28.52% | 1.15% | 4.33% | -1.58% | |
68 Neutral | $31.29B | 9.59 | 25.59% | ― | 4.24% | 20.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $8.86B | 15.81 | ― | ― | 1.27% | 118.64% | |
61 Neutral | $16.35B | 48.19 | 4.22% | 2.22% | 0.65% | ― |